Biomarker Discovery and Validation

With emphasis and advancements in personalised medicine, the need for validated biomarkers is an increasing necessity.

A fundamental aspect of personalised medicine is that laboratory tests can improve patient prognosis and predict response of individual patient treatment.

Developing a biomarker alongside a new compound, and ultimately the development of a companion diagnostic, allows correct targeting of the therapy to the right patients. This can greatly increase the treatment's likelihood of commercial success due to increased efficacy in the target population.

We can partner with customers from discovery to commercialisation to provide specific translational genomic services including:

Companion diagnostics
Pharmacodynamic (PD) Biomarkers
Prognostic tests
Drug repositioning
Consultancy
: A package of solutions tailored to meet the specific needs of the biopharma industry